This analysis, which was performed by an independent company [22], specializing in health economic research, is essentially based on a study indicating that plasma calprotectin is useful as an early complementary biomarker of bacterial infections in ICU patients [16], where WBC, PCT, and CRP may still provide valuable information. Here, CRP is linked to bacterial infectious disease.